GlassScriptPhysician profile
Casey W Melton
NPI 1790718658
$3,579.42
in general payments reported to CMS, 2019-2025
31 companies · $843 in 2025
The $843 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $567 · 2020: $74.13 · 2021: $394 · 2022: $362 · 2023: $272 · 2024: $1,067 · 2025: $843.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,082 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,081.90 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $452.16 | 2019-2025 | Trelegy Ellipta, Nucala |
| Astrazeneca Pharmaceuticals LP | $451.48 | 2019-2025 | Tezspire, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $329.84 | 2019-2025 | Ofev, Jascayd |
| Jazz Pharmaceuticals INC. | $309.64 | 2024-2025 | |
| Insmed, INC. | $213.63 | 2024-2025 | Arikayce |
| Harmony Biosciences LLC | $204.71 | 2022-2025 | Wakix |
| Avadel Cns Pharmaceuticals, LLC | $188.57 | 2023-2024 | Lumryz |
| Regeneron Healthcare Solutions, INC. | $157.53 | 2021-2025 | Dupixent |
| Mallinckrodt Hospital Products INC. | $128.75 | 2023-2025 | Acthar |
| Philips North America LLC | $124.84 | 2019-2024 | (Ak6) Vest Therapy |
| Electromed, INC. | $105.98 | 2019-2024 | Smartvest |
| Takeda Pharmaceuticals U.S.A., INC. | $100.55 | 2022-2025 | Glassia |
| United Therapeutics Corporation | $94.13 | 2022-2024 | Tyvaso |
| Sunovion Pharmaceuticals INC. | $92.25 | 2019-2020 | |
| Viatris Specialty LLC | $80.51 | 2025 | Yupelri |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Itamar Medical INC | $77.10 | 2024 | Watchpatone |
| Genzyme Corporation | $63.43 | 2025 | |
| Gilead Sciences, INC. | $60.23 | 2022 | |
| Mylan Specialty L.P. | $56.74 | 2024 | Yupelri |
| Pfizer INC. | $50.54 | 2019-2023 | |
| Pulmonx Corporation | $38.34 | 2022-2023 | Zephyr Delivery Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Genentech USA, INC. | $31.81 | 2019-2021 | |
| Grifols USA, LLC | $30.53 | 2025 | Prolastin-C Liquid |
| Ani Pharmaceuticals, INC. | $23.08 | 2023 | Purified Cortrophin Gel |
| Actelion Pharmaceuticals US, INC. | $20.92 | 2022 | |
| Axsome Therapeutics, INC. | $19.37 | 2025 | Sunosi |
| Merck Sharp & Dohme LLC | $19.16 | 2023 | Dificid, Zerbaxa, Recarbrio |
| Verona Pharma, INC. | $16.26 | 2025 | Ohtuvayre |
| Azurity Pharmaceuticals, INC. | $14.47 | 2024 | Horizant |
| Inogen, INC. | $11.48 | 2024 | |
| Allergan, INC. | $11.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Melton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.